1. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome 
Masaru Nakayama, MD, Ritsuko Katafuchi, MD, Tetsuro Yanase, MD, Kiyoshi Ikeda, MD, Hiroshi Tanaka, MD, Satoru Fujimi, MD 
American Journal of Kidney Diseases 
Volume 39, Issue 3, Pages (March 2002)
DOI: /ajkd
Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

2. Fig. 1
Response rate of adult-onset MCNS to corticosteroid therapy in our study and other reports. (○), Present study (57 patients); (■), Nolasco et al8; (▴), Korbet et al9; (□), International Study of Kidney Disease in Children5; (×), Mak et al12; and (▵), Fujimoto et al.11
American Journal of Kidney Diseases  , DOI: ( /ajkd )
Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

3. Fig. 2
Course of steroid-treated patients who entered complete remission during the first 16 weeks after starting treatment in our study and other reports. (—), Present study (44 patients); (▴), Nolasco et al8; (×), Korbet et al9; and (■), Fujimoto et al.11
American Journal of Kidney Diseases  , DOI: ( /ajkd )
Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

4. Fig. 3
Remission rate after relapse. (●), Twelve patients treated with combination cyclophosphamide therapy after relapses; (○), 10 patients treated with corticosteroids alone after relapses.
American Journal of Kidney Diseases  , DOI: ( /ajkd )
Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions